Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vemurafenib Oral Tablet [Zelboraf]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Vemurafenib is a potent serine/threonine kinase inhibitor and is registered as Zelboraf® for the treatment of metastatic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Two novel cancer drugs and their companion diagnostics to predict treatment response were given a go-ahead to market in quick… Expand